Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Friday broker round-up

Fri, 07th Sep 2012 09:03

ASOS: Jefferies keeps buy rating and 2,199p target.AstraZeneca: Morgan Stanley upgrades to equal weight.Aviva: AlphaValue downgrades to add, target lifted from 385p to 389p.Barclays: Deutsche Bank upgrades to buy.Dixons: Nomura keeps neutral rating and 20p target.Legal & General: Credit Suisse downgrades to neutral, target cut from 144p to 142p.May Gurney: Investec maintains sell rating and 100p target.Morrisons: Nomura keeps neutral rating and 300p target.Oxford Catalysts: Peel Hunt upgrades to buy, target lifted from 34p to 69p.Reed Elsevier: UBS ups target from 710p to 770p, buy rating kept.SThree: Investec maintains buy rating and 340p target.UNITE Group: Oriel Securities upgrades to add.Valiant Petroleum: Peel Hunt downgrades to hold, target cut from 600p to 525p.Vodafone: Jefferies maintains hold rating and 180p target.Whitbread: Investec raises target from 1,500p to 1,650p, sell rating kept.BC

Related Shares

More News
Today 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

Today 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.